Harvard Women's Health Watch

Progress in treating multiple myeloma

The cause of the blood disease multiple myeloma is unknown, but advances in treatment, including new medications and stem-cell transplants, are giving patients longer periods of remission.

To continue reading this article you must be registered.

Get Licensed Content to Harvard Health

If you are interested in licensing content from Harvard Health Publications, please contact us using our online form. Our licensing and business development professionals will help you leverage consumer health content from Harvard Medical School as a clear differentiator in helping achieve your business goals.

Contact Us

Customer Log In